INS and obesity disorder: Genetic deletion of RFP, whether globally or specifically in adipocytes, significantly attenuated HFD-induced obesity and associated metabolic dysfunction, including reduced adiposity, improved glucose tolerance and enhanced insulin sensitivity (Fig. 8i).